MedTrace Logo

Breast Screening - Risk Adaptive Imaging for Density

NCT04097366 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9000

Last updated 2025-03-30

No results posted yet for this study

Summary

BRAID is a randomised, multi-centre study assessing the impact of supplementary imaging in the detection of breast cancer in women participating in the UK national breast screening programme who have dense breast tissue.

Conditions

Interventions

DIAGNOSTIC_TEST

ABUS

Automated whole breast ultrasound (ABUS) is undertaken with a large transducer panel placed on the breast in three positions. Resultant images are combined to make a 3D image of the breast.

DIAGNOSTIC_TEST

CEM

A high kV and a low kV image is taken in two standard views of each breast following the intravenous injection of an iodinated contrast agent.

DIAGNOSTIC_TEST

ABB-MRI

ABB-MRI is a shorter version of breast MRI. Standard T1W pre and post contrast images are acquired. A MIP and post-contrast T1 weighted image are read.

Sponsors & Collaborators

  • Cancer Research UK

    collaborator OTHER

  • GE Healthcare

    collaborator INDUSTRY

  • Queen Mary University of London

    collaborator OTHER

  • Public Health England

    collaborator OTHER_GOV

  • University of Cambridge

    lead OTHER

Principal Investigators

  • Fiona Gilbert · University of Cambridge

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-28
Primary Completion
2024-09-30
Completion
2025-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04097366 on ClinicalTrials.gov